Generalizing evidence from randomized trials using inverse probability of sampling weights-Reference-Cited by-同舟云学术

Generalizing evidence from randomized trials using inverse probability of sampling weights

Published:2018-02-26 Issue:4 Volume:181 Page:1193-1209
ISSN:0964-1998
Container-title:Journal of the Royal Statistical Society: Series A (Statistics in Society)
language:en
Short-container-title:J. R. Stat. Soc. A

Author:

Buchanan Ashley L.¹,Hudgens Michael G.²,Cole Stephen R.²,Mollan Katie R.²,Sax Paul E.³,Daar Eric S.⁴,Adimora Adaora A.²,Eron Joseph J.²,Mugavero Michael J.⁵

Affiliation:

1. University of Rhode Island Kingston USA

2. University of North Carolina at Chapel Hill USA

3. Brigham and Women's Hospital, and Harvard Medical School Boston USA

4. Los Angeles Biomedical Research Institute at Harbor–University of California at Los Angeles Medical Center USA

5. University of Alabama Tuscaloosa USA

Funder

National Institutes of Health

University of North Carolina

Publisher

Wiley

Subject

Statistics, Probability and Uncertainty,Economics and Econometrics,Social Sciences (miscellaneous),Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/rssa.12357

Reference42 articles.

1. Social norms and energy conservation

2. Site Selection Bias in Program Evaluation *

3. Allcott H.andMullainathan S.(2012)External validity and partner selection bias.Working Paper 18373. National Bureau of Economic Research Cambridge.

4. The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Two‐Step Framework for Validating Causal Effect Estimates;Pharmacoepidemiology and Drug Safety;2024-09

2. Causal estimators for incorporating external controls in randomized trials with longitudinal outcomes;Journal of the Royal Statistical Society Series A: Statistics in Society;2024-08-26

3. Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19;Infectious Diseases and Therapy;2024-06-13

4. Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States;Journal of Medical Economics;2024-06-06

5. Re-weighting the randomized controlled trial for generalization: finite-sample error and variable selection;Journal of the Royal Statistical Society Series A: Statistics in Society;2024-05-24